Chicago, IL – November 10, 2008 – ClearTrial (www.cleartrial.com), a leading provider of software for clinical trial operations planning, budgeting, and outsourcing, announced today that Michael Soenen, ClearTrial Managing Partner, has been selected to lead a distinguished panel of top pharmaceutical portfolio management experts in discussing “Responsive Portfolio Planning: How to Effectively Incorporate Constant Change” (http://www.healthtech.com/Conferences_Overview.aspx?id=78500&c=588) at the Healthtech Portfolio Management Conference. Held at the Hyatt Regency Penn’s Landing Hotel in Philadelphia on November 18-19, 2008, the conference will bring together senior biopharma executives in portfolio and resource management to share best practices.
“Portfolio planning in clinical development remains a challenge,” Soenen observed. “Extended development timeframes are compounded by an accelerating number of changes throughout the development cycle as well as by a lack of meaningful data – forcing many organizations to make portfolio decisions based on a ‘best guess’ approach.” The panelists – senior portfolio management executives at global pharmaceutical companies – will examine common scenarios that impact portfolio planning, including shifts in development strategy and changes to study budgets, timelines, and resources. They will offer pragmatic approaches for portfolio planning that allow for the rapid pace of change in today’s clinical development environment.
As Managing Partner at ClearTrial, Soenen is responsible for overall operations and development of the company’s clinical trial operations planning software. His 20-year career has focused on providing companies in life sciences and other industries with greater efficiencies in planning, operations, and complex pricing and contract management. Before ClearTrial, Soenen worked at Andersen Consulting (Accenture), Kraft Foods, and the SRM firm Waterstone Consulting. He earned a Bachelor of Science degree in Electrical and Computer Engineering from the University of Notre Dame.
About ClearTrial®
ClearTrial is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company’s software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.
ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.
